Skip to main content

AmerisourceBergen Value Stock - Dividend - Research Selection

AmerisourceBergen

ISIN: US03073E1055, WKN: 766149

Market price date: 06.07.2022
Market price: 139,84 USD


AmerisourceBergen Fundamental data and company key figures of the share

Annual reports in USD
Key figures 06-11-2021
Cash flow
Net operating cash flow 754.656.000
Capital Expenditures -438.217.000
Free cash flow 316.439.008
Balance sheet
Total Equity 584.411.000
Liabilities & Shareholders equity 57.337.800.000
Income statement
Net income 1.544.610.000
Eps (diluted) 7,394
Diluted shares outstanding 208.912.000
Net sales/revenue 213.989.000.000

Fundamental ratios calculated on: 06-07-2022

Ratios
Key figures 06-07-2022
Cash flow
P/C 38,95
   
P/FC 92,32
Balance sheet
ROI2,69
ROE1,02
Income statement
P/E18,91
Div. Yield1,24%
P/B50,30
P/S0,14


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolABC
Market Capitalization29.396.006.912,00 USD
CountryUnited States
IndicesMSCI World Index,S&P 500
SectorsHealth Care Distributors
Raw Data SourceUS GAAP in Millionen USD
Stock Split2009-06-17,2.0000/1.0000; 2009-06-16,2.0000/1.0000; 2005-12-30,2.0000/1.0000; 2005-12-29,2.0000/1.0000; 1999-03-25,2.0000/1.0000; 1995-04-05,59.000000/20.000000
Internetwww.amerisourcebergen.com


Description of the company

AmerisourceBergen Corporation (AmerisourceBergenis) is a pharmaceutical services company serving the United States, Canada and select global markets. The Company distributes a range of pharmaceuticalsgeneric pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a range of healthcare providers located in the United States, Canada and selected global markets, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical and dialysis clinics, physicians and physician group practices, long-term care and other alternate site pharmacies, and other customers. In May 2013, the Company completed the divestiture of its contract packaging business, AndersonBrecon. In June 2013, the Company announced that has completed the divestiture of AmerisourceBergen Canada Corporation (ABCC).

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.amerisourcebergen.com


NEWS


McKesson, AmerisourceBergen and Cardinal Health Not Liable for Opioid Crisis in West Virginia, Court Rules

2022-07-05
A federal judge found that the plaintiffs, Cabell County and the city of Huntington, didn’t show that actions by McKesson, AmerisourceBergen and Cardinal Health caused the crisis.

Federal Judge Says McKesson, AmerisourceBergen, Cardinal Health Not Responsible For Opioid Epidemic: Report

2022-07-05
Federal judge David Faber rejected the efforts to force McKesson Corp (NYSE: MCK), AmerisourceBergen Corp (NYSE: ABC), and Cardinal Health Inc (NYSE: CAH) to pay $2.5 billion for the opioid crisis. The judge ruled that the drug distributors are not responsible for fueling an opioid epidemic in a part of West Virginia, Reuters reported. Faber said the companies did not cause any oversupply of opioids, saying doctors' "good faith" prescribing decisions drove the volume of painkillers they shipped

McKesson, Cardinal, AmerisourceBergen not liable for WV opioid crisis, WSJ says

2022-07-05
Federal U.S. District jud... MCK, CAH, ABC

Federal judge rules in favor of drug distributors in West Virginia opioid case

2022-07-05
A West Virginia federal judge has ruled in favor of three wholesale drug distributors, stating they cannot be held responsible for the opioid crisis affecting communities in the state.The ruling... | July 5, 2022

U.S. drug distributors prevail in $2.5 billion West Virginia opioid case

2022-07-04
McKesson Corp, AmerisourceBergen Corp and Cardinal Health Inc are not responsible for fueling an opioid epidemic in a part of West Virginia, a federal judge ruled on Monday.

'Minions: The Rise of Gru' tops $108 million as parents flock back to cinemas, kids in tow

2022-07-03
"Minions: The Rise of Gru" generated more than $108 million in ticket sales during its domestic opening weekend.

AMERISOURCEBERGEN CORP : Other Events (form 8-K)

2022-07-01
Item 8.01. Other Events.On June 27, 2022, AmerisourceBergen Corporation and two othernational pharmaceutical distributors entered into an agreement with the State ofOklahoma to resolve... | July 1, 2022

WVa opioid trial verdict still pending nearly a year later

2022-07-01
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

August 12th Options Now Available For AmerisourceBergen (ABC)

2022-06-30
Staff article entitled August 12th Options Now Available For AmerisourceBergen (ABC), about stock options, from Stock Options Channel.

AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2022 Earnings Release

2022-06-29
CONSHOHOCKEN, Pa., June 29, 2022--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter of Fiscal 2022 on Wednesday, August 3, 2022, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on August 3, 2022.